Disruptions in Availability of Breast Biopsy Needles - Letter to Health Care Providers
The FDA issued a LHCP to notify providers that Stereotactic Breast Biopsy Needles (product code KNW)...
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- FDA MedWatch
- Region
- USA
- Scope
- Regulatory
- Published
- June 16, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The FDA issued a LHCP to notify providers that Stereotactic Breast Biopsy Needles (product code KNW)...
Source route
Continue on fda.gov
Leave the platform to read the original full article on the publisher site.
Source: FDA MedWatch
Scope: Regulatory
Related coverage
More related coverage
Drug label update: unspecified product
Official structured record identifier: 52cef8ec-6578-5e80-e063-6294a90ab423.
DHSC spending over £500
This series brings together all documents relating to Department of Health and Social Care (DHSC) sp...
DHSC: spending over £500, May 2026
Department of Health and Social Care spending by electronic purchasing card solution (ePCS), over £5...